Clinical and Imaging Data-Based Model for Predicting Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in Pregnant Women With Severe Preeclampsia or Eclampsia and Analysis of Perinatal Outcomes

Table 2

Laboratory test results of two groups (laboratory model).

Category	RPLS group	Non-RPLS group	Univariate analysis		Multivariate analysis
	(n = 33)	(n = 45)	X^2/t			Hazard ratio
RBC (x10^12/L)	4.16 ± 0.355	4.04 ± 0.315	1.55	0.124
Hb (g/L)	113.31 ± 24.26	113.11 ± 19.43	0.038	0.97
WBC (x10^9/L)	12.21 ± 1.99	11.02 ± 2.22	2.415	0.018	0.011	0.641 (0.456–0.902)
PLT (x10^9/L)	177.58 ± 43.81	215.12 ± 48.67	3.507	0.001	0.010	1.023 (1.005–1.040)
APTT (s)	31.97 ± 2.01	32.08 ± 2.36	0.227	0.821
24 h urinary protein (g)	4.82 ± 1.69	5.37 ± 1.95	1.33	0.198
LDH (U/L)	583.39 ± 112.68	525.34 ± 120.61	2.158	0.034	0.032	0.994 (0.989–1.000)
AST (U/L)	151.69 ± 38.61	138.71 ± 35.98	1.509	0.135
ALT (U/L)	110.74 ± 22.21	97.74 ± 21.87	2.576	0.012	0.006	0.959 (0.930–0.988)
Uric acid (mmol/L)	558.12 ± 87.31	496.27 ± 72.82	3.406	0.001	0.039	0.992 (0.984–1.000)
TC (mmol/L)	5.73 ± 1.48	5.84 ± 1.28	0.347	0.73
Urea nitrogen (mmol/L)	5.95 ± 1.59	5.98 ± 1.81	0.095	0.925
Creatinine (μmol/L)	65.94 ± 21.88	69.33 ± 16.91	0.772	0.442
Serum albumin (g/L)	23.82 ± 3.29	25.88 ± 3.05	2.840	0.006	0.042	1.241 (1.008–1.525)